Search

Jun 18, 2024
After exiting stealth mode with $190M today, Marea Therapeutics' Co-Founder Ethan Weiss describes ANGPTL4 as a cardiometabolic target and more
Cardiology expert Ethan Weiss describes the difference between ANGPTL4 and ANGPLT3, the rationale for lowering remnant cholesterol,...